TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32054513

Group type: EXPERIMENTAL
Intervention: Business card given to patients (group 1)
Number of subjects: 141

Group type: COMPARATOR
Intervention: No business card given to patients (group 2)
Number of subjects: 141
Study: 32845283

Group type: EXPERIMENTAL
Intervention: Telmisartan, 40 mg
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 36403036

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 230
Study: 32049588

Group type: EXPERIMENTAL
Intervention: Minimal Repeats group (rarely experienced repeating stimuli on consecutive trials)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frequent Repeats group (frequently presented with repeating stimuli on consecutive trials)
Number of subjects: 0
Study: 35039595

Group type: EXPERIMENTAL
Intervention: 600 mg ibuprofen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 200 mg ibuprofen
Number of subjects: 20
Study: 33588872

Group type: EXPERIMENTAL
Intervention: Chicken broth (CB)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo soup
Number of subjects: 14
Study: 616761523

Group type: EXPERIMENTAL
Intervention: Web-based training (online video modules, discussions, assessments)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional training (1-day live training)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Web-based training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 71
Study: 34345911

Group type: EXPERIMENTAL
Intervention: TCFA-positive patients (n=98)
Number of subjects: 550

Group type: COMPARATOR
Intervention: TCFA-negative patients (n=292)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: TCFA
Number of subjects: 550
Study: 36037744

Group type: COMPARATOR
Intervention: ST + PNF training
Number of subjects: 60

Group type: COMPARATOR
Intervention: ST + PNF training + TEAS intervention
Number of subjects: 60
Study: 34197764

Group type: EXPERIMENTAL
Intervention: CoronaVac 1.5 μg
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CoronaVac 3.0 μg
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CoronaVac 1.5 μg (phase 2)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: CoronaVac 3.0 μg (phase 2)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Alum only (control)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: All groups (safety profile)
Number of subjects: 550
Study: 32920241

Group type: EXPERIMENTAL
Intervention: Outcome-based incentives
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Process-based incentives
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Combination of outcome- and process-based incentives
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Choice-based incentives
Number of subjects: 400

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 400
Study: 36078179

Group type: EXPERIMENTAL
Intervention: HRV-guided training (HRV-G)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Predefined training (PRED-G)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both HRV-G and PRED-G
Number of subjects: 21
Study: 34225767

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (4000 IU/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 33538329

Group type: EXPERIMENTAL
Intervention: Online decision aid (counseling followed by the additional use of the decision aid)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (counseling only)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 32150232

Group type: EXPERIMENTAL
Intervention: Gabapentin up to 1200 mg/d, orally, with 9 medical management visits (20 minutes each)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Gabapentin in high-alcohol withdrawal group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo with 9 medical management visits (20 minutes each)
Number of subjects: 96
Study: 32540236

Group type: EXPERIMENTAL
Intervention: Topical treatments for actinic keratosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DCE (Discrete Choice Experiment) at baseline and final post-treatment assessment
Number of subjects: 0
Study: 34237313

Group type: EXPERIMENTAL
Intervention: nVNS (transcutaneous vagal nerve stimulation)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham nVNS
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: nVNS (open-label phase)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham nVNS (open-label phase)
Number of subjects: 27
Study: 36774110

Group type: EXPERIMENTAL
Intervention: 400 IU/d of supplemental cholecalciferol (vitamin D3)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 1000 IU/d of supplemental cholecalciferol (vitamin D3)
Number of subjects: 98
Study: 34319769

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 23360

Group type: EXPERIMENTAL
Intervention: Dietary Modification (Women's Health Initiative)
Number of subjects: 23360

Group type: COMPARATOR
Intervention: Conjugated equine estrogen (Women's Health Initiative)
Number of subjects: 23360
Study: 35387833

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical thrombectomy (MT) with alteplase
Number of subjects: 0
Study: 33048570

Group type: EXPERIMENTAL
Intervention: OurRelationship and ePREP online relationship programs
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (matched civilian sample)
Number of subjects: 90
Study: 36212173

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg·kg‐1·h‐1 before and during anesthesia, 0.2 μg·kg‐1·h‐1 after induction)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 100
Study: 34043996

Group type: EXPERIMENTAL
Intervention: N95 mask without an exhalation valve
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: N95 mask with an exhalation valve
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no mask)
Number of subjects: 22
Study: 33339973

Group type: EXPERIMENTAL
Intervention: Periodontitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Periodontal therapy
Number of subjects: 0
Study: 35099429

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 44

Group type: COMPARATOR
Intervention: Isometric exercises
Number of subjects: 44
Study: 33114585

Group type: EXPERIMENTAL
Intervention: 35 g protein (MOD)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 70 g protein (HIGH)
Number of subjects: 8
Study: 35812118

Group type: EXPERIMENTAL
Intervention: Acupuncture arm 1
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Acupuncture arm 2
Number of subjects: 497

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 497
Study: 33867179

Group type: EXPERIMENTAL
Intervention: Sucralfate (20 mg/kg per dose up to 1 g)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34706404

Group type: EXPERIMENTAL
Intervention: Mind Sound Resonance Technique (MSRT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supine Rest (SR)
Number of subjects: 32
Study: 33225377

Group type: EXPERIMENTAL
Intervention: Eluvia
Number of subjects: 440

Group type: COMPARATOR
Intervention: Zilver PTX
Number of subjects: 440
Study: 35343425

Group type: EXPERIMENTAL
Intervention: School Feeding Program (SFP)
Number of subjects: 4500
Study: 34810348

Group type: EXPERIMENTAL
Intervention: 4% articaine buccal infiltration
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% lidocaine inferior alveolar nerve block
Number of subjects: 40
Study: 32867790

Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing cyproterone acetate (CPA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral contraceptives containing desogestrel (DSG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral contraceptives containing drospirenone (DRSP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oral contraceptives containing levonorgestrel (LNG)
Number of subjects: 200
Study: 34923493

Group type: EXPERIMENTAL
Intervention: 1-year lifestyle programme focusing on a largely plant-based diet, physical activity, stress management, and community support
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: 1-year lifestyle programme
Number of subjects: 201
Study: 32299659

Group type: EXPERIMENTAL
Intervention: Multimodal educational intervention
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 82
Study: 32171186

Group type: EXPERIMENTAL
Intervention: Targeted skin products
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 35653287

Group type: EXPERIMENTAL
Intervention: Best double variant I97L/G195A
Number of subjects: 0
Study: 34158383

Group type: EXPERIMENTAL
Intervention: Bedside rounding
Number of subjects: 79

Group type: COMPARATOR
Intervention: Hallway rounding
Number of subjects: 79

Group type: COMPARATOR
Intervention: Residents' perception of hallway rounding
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Nurses' perception of bedside rounds
Number of subjects: 79

Group type: COMPARATOR
Intervention: Patients' views on rounding
Number of subjects: 79
Study: 35384807

Group type: EXPERIMENTAL
Intervention: Structured education (Group 1, n = 140)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional education (Group 2, n = 70)
Number of subjects: 210
Study: 33787345

Group type: EXPERIMENTAL
Intervention: Oral prednisone at a dose of 1 mg/kg/day followed by weekly stepwise tapering in steps of 10 mg/day
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Oral prednisone
Number of subjects: 155
Study: 32952824

Group type: EXPERIMENTAL
Intervention: Ivermectin administration over seven years
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Ivermectin administration
Number of subjects: 310
Study: 36324229

Group type: EXPERIMENTAL
Intervention: Interferon β‐1a (7.5–30 μg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Pegylated interferon β‐1a (31.25–125 μg)
Number of subjects: 84
Study: 33399860

Group type: EXPERIMENTAL
Intervention: Underreporting multipliers derived from CDC seroprevalence studies
Number of subjects: 100368

Group type: COMPARATOR
Intervention: Reported COVID-19 infections adjusted using underreporting multipliers
Number of subjects: 100368
Study: 35422071

Group type: EXPERIMENTAL
Intervention: Piezocision procedure
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 33811354

Group type: EXPERIMENTAL
Intervention: Chinese version of the Baby Eating Behaviour Questionnaire (BEBQ)
Number of subjects: 300
Study: 32366799

Group type: EXPERIMENTAL
Intervention: Positive preexercise information
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Negative preexercise information
Number of subjects: 83

Group type: COMPARATOR
Intervention: Neutral preexercise information
Number of subjects: 83
Study: 35259753

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (E.S.)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (Medication, massage, and facial exercise)
Number of subjects: 45
Study: 32212009

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 35716984

Group type: EXPERIMENTAL
Intervention: ChloraPrep™ (2% chlorhexidine gluconate and 70% isopropyl alcohol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Betadine® Surgical Scrub and Betadine® 5% solution (povidone‐iodine)
Number of subjects: 30
Study: 33038832

Group type: COMPARATOR
Intervention: Omega-3 LCPUFA supplementation
Number of subjects: 5544

Group type: COMPARATOR
Intervention: Control (no omega-3 LCPUFA supplementation)
Number of subjects: 5544
Study: 36209067

Group type: EXPERIMENTAL
Intervention: Group Schema Therapy (GST)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Individual Schema Therapy (IST)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Severity of Cluster-C PD
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Functioning and wellbeing
Number of subjects: 378
Study: 33933271

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (gas flow 70 L min−1, inspired oxygen fraction 0.50)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Standard oxygen (delivered via nasal cannula or face mask at 6 L min−1 or nasopharyngeal tube at 5 L min−1)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen
Number of subjects: 379

Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 379
Study: 32409778

Group type: EXPERIMENTAL
Intervention: Home/community-based exercise intervention for 6 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Wait-List Control
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Home/community-based exercise intervention
Number of subjects: 84
Study: 34588153

Group type: EXPERIMENTAL
Intervention: Web-based and machine learning approaches for identifying patient-reported outcomes
Number of subjects: 20
Study: 33210508

Group type: EXPERIMENTAL
Intervention: J‐pouch surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Side‐to-end anastomoses (S‐E)
Number of subjects: 90

Group type: COMPARATOR
Intervention: End‐to‐end anastomoses (E‐E)
Number of subjects: 90
Study: 34600960

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) combined with fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoxetine alone
Number of subjects: 0
Study: 33893337

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 109

Group type: COMPARATOR
Intervention: Tocilizumab
Number of subjects: 109

Group type: COMPARATOR
Intervention: Higher neutrophil/Lymphocyte ratio
Number of subjects: 109

Group type: COMPARATOR
Intervention: Lower PaO2/FiO2, 2 days after treatment
Number of subjects: 109
Study: 36170988

Group type: EXPERIMENTAL
Intervention: safetxt intervention (text messages)
Number of subjects: 6248

Group type: COMPARATOR
Intervention: Control (monthly text message)
Number of subjects: 6248
Study: 33468208

Group type: EXPERIMENTAL
Intervention: Mingjing granule as an add-on to intravitreous ranibizumab
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 180
Study: 35612103

Group type: EXPERIMENTAL
Intervention: Data-driven knowledge representation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing terminologies
Number of subjects: 0
Study: 33950082

Group type: COMPARATOR
Intervention: Control group (flat archwires progressively to 0.016x0.022‐in stainless‐steel)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Experimental group (0.014‐in‐superelastic NiTi with mild accentuated COS for aligning, then 0.016x0.022‐in beta‐titanium accentuated COS archwires for leveling)
Number of subjects: 30
Study: 36210358

Group type: EXPERIMENTAL
Intervention: Video augmented mirror therapy (MTVADG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Traditional mirror therapy (TMTG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study: 34371893

Group type: EXPERIMENTAL
Intervention: High flavonoid foods added to daily diet
Number of subjects: 41
Study: 35239783

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF, 5 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA, cellulose)
Number of subjects: 9
Study: 32801255

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (Hb <7 g/dl)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (Hb <8 g/dl)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 224

Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 224
Study: 33185650

Group type: EXPERIMENTAL
Intervention: Vericiguat titrated to 10 mg daily
Number of subjects: 5050

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5050

Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5050
Study: 32608933

Group type: EXPERIMENTAL
Intervention: Variable rotational flywheel training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard rotational flywheel training
Number of subjects: 24
Study: 36283068

Group type: EXPERIMENTAL
Intervention: Silane application with universal adhesives (Scotchbond Universal, All‐Bond Universal, G‐Premio Bond, Clearfil SE Bond)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Photo-polymerization of universal adhesives
Number of subjects: 80
Study: 34845786

Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 8581

Group type: COMPARATOR
Intervention: Non-CVS
Number of subjects: 8581

Group type: COMPARATOR
Intervention: Matched non-CVS
Number of subjects: 8581
Study: 35688593

Group type: EXPERIMENTAL
Intervention: ACTforIBD programme (8-week intervention with 1-hour sessions, including 3 one-to-one sessions with a psychologist and self-directed online sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 50
Study: 33839938

Group type: EXPERIMENTAL
Intervention: Deep learning model based on images
Number of subjects: 601

Group type: COMPARATOR
Intervention: Radiomics model
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Deep learning combined with clinical parameters (DLC) model
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: DLC models for MVI-grade stratification
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: DLC-predicted MVI status
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Hepatectomy with wide resection margin
Number of subjects: 601
Study: 33136237

Group type: EXPERIMENTAL
Intervention: AAV-based gene therapy (e.g., Luxturna® - voretigene neparvovec‐rzyl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AAV-based therapies
Number of subjects: 0
Study: 35331719

Group type: COMPARATOR
Intervention: MET‐only
Number of subjects: 75

Group type: COMPARATOR
Intervention: MET+STM
Number of subjects: 75
Study: 33180609

Group type: EXPERIMENTAL
Intervention: Nasojejunal (NJ) tube feeding
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nasogastric (NG) tube feeding
Number of subjects: 40
Study: 32683635

Group type: EXPERIMENTAL
Intervention: KRAS mutations
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Exon 4 KRAS mutations
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Exon 2 KRAS mutations
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Exon 3 KRAS mutations
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: NRAS mutations
Number of subjects: 938
Study: 33736584

Group type: EXPERIMENTAL
Intervention: Optimal positive end-expiratory pressure (n = 28)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (fixed positive end-expiratory pressure, 5 cm H₂O; n = 29)
Number of subjects: 57
Study: 32586939

Group type: EXPERIMENTAL
Intervention: Letrozole plus bevacizumab
Number of subjects: 294

Group type: COMPARATOR
Intervention: Letrozole alone
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: CTC-positive patients
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Failure to clear CTCs during treatment
Number of subjects: 294
Study: 34957321

Group type: EXPERIMENTAL
Intervention: Simulation scenario of unconscious person with physiological breathing (15/min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Simulation scenario of gasping (<10/min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Simulation scenario of apnea (resuscitation dummy AmbuMan® Wireless)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Self-assessment of preparedness for resuscitation situations
Number of subjects: 102
Study: 35643841

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin use
Number of subjects: 0
Study: 34024696

Group type: EXPERIMENTAL
Intervention: Myofascial Release (MFR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study: 32569172

Group type: EXPERIMENTAL
Intervention: Unilateral balloon kyphoplasty (BKP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Bilateral balloon kyphoplasty (BKP)
Number of subjects: 150
Study: 36240214

Group type: EXPERIMENTAL
Intervention: Medication Management Review (MMR) service
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no MMR service)
Number of subjects: 106
Study: 34611236

Group type: EXPERIMENTAL
Intervention: Real direct current stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham direct current stimulation
Number of subjects: 14
Study: 32379581

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PRP injection into pathological shoulder tendons targeting the supraspinatus
Number of subjects: 6
Study: 33720418

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 2377

Group type: COMPARATOR
Intervention: Control group (n = 9,204 for APT, n = 9,196 for ARS, n = 8,788 for AOM)
Number of subjects: 2377

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2377
Study: 32690791

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg infusions every 24 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon (IFN)‐β‐1a (44 μg 3 times weekly)
Number of subjects: 0
Study: 35232596

Group type: EXPERIMENTAL
Intervention: liq PCV-free HRV
Number of subjects: 1351

Group type: COMPARATOR
Intervention: lyo HRV
Number of subjects: 1351
Study: 32427108

Group type: EXPERIMENTAL
Intervention: iCAN-DO intervention (Step 1: access to psychoeducational material and peer support; Step 2: internet-based cognitive behavioral therapy)
Number of subjects: 15
Study: 36007555

Group type: EXPERIMENTAL
Intervention: Ultra-low contrast percutaneous coronary intervention (ULC-PCI)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 82
Study: 32714133

Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular therapies
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RAS
Number of subjects: 30